Klk Capital Management LLC Incyte Corp Transaction History

Klk Capital Management LLC

  • $75.7 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022
SELL
$66.02 - $79.71 $613,127 - $740,266
-9,287 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$68.67 - $84.02 $40,103 - $49,067
-584 Reduced 5.92%
9,287 $639,000
Q2 2021

Aug 13, 2021
BUY
$79.87 - $87.53 $788,396 - $864,008
9,871 New
9,871 $830,000

Others Institutions Holding INCY

# of Institutions
624
Shares Held
197M
Call Options Held
766K
Put Options Held
476K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Klk Capital Management LLC Portfolio

Follow Klk Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klk Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klk Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email